Oramed Pharmaceuticals Inc. (ORMP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Oramed Pharmaceuticals In...

NASDAQ: ORMP · Real-Time Price · USD
2.23
0.01 (0.45%)
At close: Sep 05, 2025, 3:56 PM
2.18
-2.02%
After-hours: Sep 05, 2025, 04:45 PM EDT

Oramed Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
Revenue
n/a 1.34M 2.7M 2.7M
Cost of Revenue
193K n/a n/a n/a
Gross Profit
-193K 1.34M 2.7M 2.7M
Operating Income
-12.78M -15.77M -40.6M -24.22M
Interest Income
n/a 8.03M 3.57M 347K
Pretax Income
-15.92M 5.09M -37.66M -22.99M
Net Income
-19.1M 5.53M -37.76M -22.24M
Selling & General & Admin
6.46M 8.14M 15.66M 5.94M
Research & Development
6.32M 8.97M 27.64M 20.99M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
12.78M 17.11M 43.3M 26.93M
Interest Expense
853K 3.58M n/a 6K
Selling & Marketing Expenses
n/a -287K 1.85M n/a
Cost & Expenses
12.78M 17.11M 43.3M 26.93M
Income Tax Expense
3.18M n/a 100K -2.88M
Shares Outstanding (Basic)
40.83M 40.32M 39M 28.47M
Shares Outstanding (Diluted)
40.83M 40.57M 39M 28.47M
EPS (Basic)
-0.47 0.14 -0.97 -0.78
EPS (Diluted)
-0.47 0.14 -0.97 -0.78
EBITDA
-14.87M -15.57M -36.98M -25.04M
EBIT
-15.07M 7.13M -40.6M n/a
Depreciation & Amortization
193K 196K 3.62M 77K